Identification of a pharmacological target for genioglossus reactivation throughout sleep

Sleep

Volumn 37, Issue 1, 2014, Pages 41-50

  Grace, Kevin P ^a   Hughes, Stuart W ^b   Horner, Richard L ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

Animal models; Genioglossus; Obstructive sleep apnea; Sleep; Upper airway

Indexed keywords

4 AMINOPYRIDINE; BARIUM; INWARDLY RECTIFYING POTASSIUM CHANNEL; METHANANDAMIDE; TETRYLAMMONIUM; VOLTAGE GATED POTASSIUM CHANNEL;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; GENIOGLOSSUS; HYPOGLOSSAL NERVE; MALE; MOTOR ACTIVITY; MUSCLE; MUSCLE CONTRACTION; NERVE EXCITABILITY; NONHUMAN; PERFUSION; PRIORITY JOURNAL; RAT; REM SLEEP; SLEEP; SLEEP DISORDERED BREATHING; WAKEFULNESS;

ANIMAL MODELS; GENIOGLOSSUS; OBSTRUCTIVE SLEEP APNEA; SLEEP; UPPER AIRWAY;

ANIMALS; BARIUM; HYPOGLOSSAL NERVE; MALE; MOTOR NEURONS; PHARYNGEAL MUSCLES; PHARYNX; POLYSOMNOGRAPHY; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; RATS; RATS, WISTAR; SLEEP; SLEEP APNEA, OBSTRUCTIVE; SLEEP, REM; TONGUE; WAKEFULNESS;

EID: 84891816948     PISSN: 01618105     EISSN: 15509109     Source Type: Journal    
DOI: 10.5665/sleep.3304     Document Type: Article

References (59)

1. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000;342:1378-84.
2. Malhotra A, White DP. Obstructive sleep apnoea. Lancet 2002;360:237-45.
3. Brooks D, Horner RL, Kozar LF, Render-Teixeira CL, Phillipson EA. Obstructive sleep apnea as a cause of systemic hypertension. Evidence from a canine model. J Clin Invest 1997;99:106-9.
4. Teran-Santos J, Jimenez-Gomez A, Cordero-Guevara J. The association between sleep apnea and the risk of traffic accidents. Cooperative Group Burgos-Santander. N Engl J Med 1999;340:847-51.
5. Eastwood PR, Malhotra A, Palmer LJ, et al. Obstructive sleep apnoea: from pathogenesis to treatment: current controversies and future directions. Respirology 2010;15:587-95.
6. Remmers JE, deGroot WJ, Sauerland EK, Anch AM. Pathogenesis of upper airway occlusion during sleep. J Appl Physiol 1978;44:931-8.
7. Lin CM, Huang YS, Guilleminault C. Pharmacotherapy of obstructive sleep apnea. Expert Opin Pharmacother 2012;13:841-57.
8. Smith I, Lasserson TJ, Wright J. Drug therapy for obstructive sleep apnoea in adults. Cochrane Database Syst Rev 2006(2):CD003002.
9. Smith IE, Quinnell TG. Pharmacotherapies for obstructive sleep apnoea: where are we now? Drugs 2004;64:1385-99.
10. Dempsey JA, Veasey SC, Morgan BJ, O'Donnell CP. Pathophysiology of sleep apnea. Physiol Rev 2010;90:47-112.
11. Veasey SC. Will we ever have an effective pharmacotherapy for obstructive sleep apnea? Sleep 2005;28:18-9.
12. Horner RL. Emerging principles and neural substrates underlying tonic sleep-state-dependent influences on respiratory motor activity. Philos Trans R Soc Lond B Biol Sci 2009;364:2553-64.
13. Chan E, Steenland HW, Liu H, Horner RL. Endogenous excitatory drive modulating respiratory muscle activity across sleep-wake states. Am J Respir Crit Care Med 2006;174:1264-73.
14. Steenland HW, Liu H, Horner RL. Endogenous glutamatergic control of rhythmically active mammalian respiratory motoneurons in vivo. J Neurosci 2008;28:6826-35.
15. Fenik VB, Davies RO, Kubin L. REM sleep-like atonia of hypoglossal (XII) motoneurons is caused by loss of noradrenergic and serotonergic inputs. Am J Respir Crit Care Med 2005;172:1322-30.
16. Burgess C, Lai D, Siegel J, Peever J. An endogenous glutamatergic drive onto somatic motoneurons contributes to the stereotypical pattern of muscle tone across the sleep-wake cycle. J Neurosci 2008;28:4649-60.
17. Grace KP, Hughes SW, Horner RL. Identification of the mechanism mediating genioglossus muscle suppression in REM sleep. Am J Respir Crit Care Med 2013;187:311-9.
18. Horner RL. Neuromodulation of hypoglossal motoneurons during sleep. Respir Physiol Neurobiol 2008;164:179-96.
19. Horner RL, Liu X, Gill H, Nolan P, Liu H, Sood S. Effects of sleep-wake state on the genioglossus vs.diaphragm muscle response to CO(2) in rats. J Appl Physiol 2002;92:878-87.
20. Talley EM, Lei Q, Sirois JE, Bayliss DA. TASK-1, a two-pore domain K+ channel, is modulated by multiple neurotransmitters in motoneurons. Neuron 2000;25:399-410.
21. Bayliss DA, Viana F, Talley EM, Berger AJ. Neuromodulation of hypoglossal motoneurons: cellular and developmental mechanisms. Respir Physiol 1997;110:139-50.
22. Hibino H, Inanobe A, Furutani K, Murakami S, Findlay I, Kurachi Y. Inwardly rectifying potassium channels: their structure, function, and physiological roles. Physiol Rev 2010;90:291-366.
23. Topert C, Doring F, Wischmeyer E, et al. Kir2.4: a novel K+ inward rectifier channel associated with motoneurons of cranial nerve nuclei. J Neurosci 1998;18:4096-105.
24. Bayliss DA, Viana F, Berger AJ. Mechanisms underlying excitatory effects of thyrotropin-releasing hormone on rat hypoglossal motoneurons in vitro. J Neurophysiol 1992;68:1733-45.
25. Fisher ND, Nistri A. A study of the barium-sensitive and -insensitive components of the action of thyrotropin-releasing hormone on lumbar motoneurons of the rat isolated spinal cord. Eur J Neurosci 1993;5:1360-9.
26. Halliwell JV, Adams PR. Voltage-clamp analysis of muscarinic excitation in hippocampal neurons. Brain Res 1982;250:71-92.
27. Constanti A, Galvan M. M-current in voltage-clamped olfactory cortex neurones. Neurosci Lett 1983;39:65-70.
28. Grace KP, Liu H, Horner RL. 5-HT1A receptor-responsive pedunculopontine tegmental neurons suppress REM sleep and respiratory motor activity. J Neurosci 2012;32:1622-33.
29. Chen ZJ, Gillies GT, Broaddus WC, et al. A realistic brain tissue phantom for intraparenchymal infusion studies. J Neurosurg 2004;101:314-22.
30. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. 4th ed. San Diego: Academic Press, 1998.
31. Gervasoni D, Lin SC, Ribeiro S, Soares ES, Pantoja J, Nicolelis MA. Global forebrain dynamics predict rat behavioral states and their transitions. J Neurosci 2004;24:11137-47.
32. Enyedi P, Czirjak G. Molecular background of leak K+ currents: two-pore domain potassium channels. Physiol Rev 2010;90:559-605.
33. Berg AP, Talley EM, Manger JP, Bayliss DA. Motoneurons express heteromeric TWIK-related acid-sensitive K+ (TASK) channels containing TASK-1 (KCNK3) and TASK-3 (KCNK9) subunits. J Neurosci 2004;24:6693-702.
34. Maingret F, Patel AJ, Lazdunski M, Honore E. The endocannabinoid anandamide is a direct and selective blocker of the background K(+) channel TASK-1. EMBO J 2001;20:47-54.
35. Coburn C, Wang J, Santarelli V, et al. (Merck & Co., West Point, USA). TASK Channel Antagonists. Int. Pat. Appl. WO 2011/103715, 2011.
36. Brendel J, Goegelein H, Wirth K, Kamm W. (Sanofi-Aventis Deutschland GMBh, Frankfurt-Am-Main, Germany). Inhibitors of the TASK-1 and TASK-3 Ion Channel. Int. Pat. Appl. WO 2007/124849, 2007.
37. Coburn CA, Luo Y, Cui M, et al. Discovery of a pharmacologically active antagonist of the two-pore-domain potassium channel K2P9.1 (TASK-3). Chem Med Chem 2011;7:123-33.
38. Wulff H, Castle NA, Pardo LA. Voltage-gated potassium channels as therapeutic targets. Nat Rev Drug Discov 2009;8:982-1001.
39. Dodson PD, Forsythe ID. Presynaptic K+ channels: electrifying regulators of synaptic terminal excitability. Trends Neurosci 2004;27:210-7.
40. Linden AM, Sandu C, Aller MI, et al. TASK-3 knockout mice exhibit exaggerated nocturnal activity, impairments in cognitive functions, and reduced sensitivity to inhalation anesthetics. J Pharmacol Exp Ther 2007;323:924-34.
41. Linden AM, Aller MI, Leppa E, Rosenberg PH, Wisden W, Korpi ER. K+ channel TASK-1 knockout mice show enhanced sensitivities to ataxic and hypnotic effects of GABA(A) receptor ligands. J Pharmacol Exp Ther 2008;327:277-86.
42. Brickley SG, Revilla V, Cull-Candy SG, Wisden W, Farrant M. Adaptive regulation of neuronal excitability by a voltage-independent potassium conductance. Nature 2001;409:88-92.
43. Mukhtarov M, Ragozzino D, Bregestovski P. Dual Ca2+ modulation of glycinergic synaptic currents in rodent hypoglossal motoneurones. J Physiol 2005;569:817-31.
44. Kennard LE, Chumbley JR, Ranatunga KM, Armstrong SJ, Veale EL, Mathie A. Inhibition of the human two-pore domain potassium channel, TREK-1, by fluoxetine and its metabolite norfluoxetine. Br J Pharmacol 2005;144:821-9.
45. Mackie K, Devane WA, Hille B. Anandamide, an endogenous cannabinoid, inhibits calcium currents as a partial agonist in N18 neuroblastoma cells. Mol Pharmacol 1993;44:498-503.
46. Chemin J, Monteil A, Perez-Reyes E, Nargeot J, Lory P. Direct inhibition of T-type calcium channels by the endogenous cannabinoid anandamide. EMBO J 2001;20:7033-40.
47. Poling JS, Rogawski MA, Salem N Jr, Vicini S. Anandamide, an endogenous cannabinoid, inhibits Shaker-related voltage-gated K+ channels. Neuropharmacology 1996;35:983-91.
48. Viana F, Bayliss DA, Berger AJ. Multiple potassium conductances and their role in action potential repolarization and repetitive firing behavior of neonatal rat hypoglossal motoneurons. J Neurophysiol 1993;69:2150-63.
49. Grissmer S, Nguyen AN, Aiyar J, et al. Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines. Mol Pharmacol 1994;45:1227-34.
50. Stephens GJ, Garratt JC, Robertson B, Owen DG. On the mechanism of 4-aminopyridine action on the cloned mouse brain potassium channel mKv1.1. J Physiol 1994;477:187-96.
51. Kavanaugh MP, Varnum MD, Osborne PB, et al. Interaction between tetraethylammonium and amino acid residues in the pore of cloned voltage-dependent potassium channels. J Biol Chem 1991;266:7583-7.
52. Coetzee WA, Amarillo Y, Chiu J, et al. Molecular diversity of K+ channels. Ann N Y Acad Sci 1999;868:233-85.
53. Fedida D, Bouchard R, Chen FS. Slow gating charge immobilization in the human potassium channel Kv1.5 and its prevention by 4-aminopyridine. J Physiol 1996;494:377-87.
54. Fedida D, Wible B, Wang Z, et al. Identity of a novel delayed rectifier current from human heart with a cloned K+ channel current. Circ Res 1993;73:210-6.
55. Kalman K, Nguyen A, Tseng-Crank J, et al. Genomic organization, chromosomal localization, tissue distribution, and biophysical characterization of a novel mammalian Shaker-related voltage-gated potassium channel, Kv1.7. J Biol Chem 1998;273:5851-7.
56. Wang HS, Pan Z, Shi W, et al. KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel. Science 1998;282:1890-3.
57. Yang WP, Levesque PC, Little WA, et al. Functional expression of two KvLQT1-related potassium channels responsible for an inherited idiopathic epilepsy. J Biol Chem 1998;273:19419-23.
58. Bailey EF, Fridel KW, Rice AD. Sleep/wake firing patterns of human genioglossus motor units. J Neurophysiol 2007;98:3284-91.
59. Saboisky JP, Butler JE, Fogel RB, et al. Tonic and phasic respiratory drives to human genioglossus motoneurons during breathing. J Neurophysiol 2006;95:2213-21.